glp 1 market size GLP-1 Agonists Report 2025-2033, By Product, Molecule, and Geo GLP-1 Receptor Agonist Market Size,

Three more gliptins, teneligliptin, anagliptin, and trelagliptin are only approved in the Japanese and Korean market

Futhermore, 2025 results from the ATTAIN-MAINTAIN trial demonstrated orforgliprons ability to compete in the maintenance segment

How PlexusDx Simplifies Access to Semaglutide Treatment PlexusDx eliminates common barriers to GLP-1 therapy by offering flat-rate monthly pricing without dose-based cost increases, serving all 50 states with no insurance required

This analysis examines publicly available formularies of plans available on the federally facilitated Affordable Care Act (ACA) Marketplace in 2024 to identify how utilization management tools are used for GLP-1 agonists

Exhale for four seconds

Available from: Deanfield J, Verma S, Scirica BM, Kahn SE, Emerson SS, Ryan D et al (2024) Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial